Home » Newsletters » BioWorld Science

BioWorld Science

June 27, 2014

View Archived Issues

Visual acuity improvement seen in interim results from squalamine eye drops trial

Optimization of a GPR40 agonist for type 2 diabetes

Aurigene and Orion form BET bromodomain collaboration

Nandrolone decanoate/vitamin D3 fixed-dose combination evaluated in multiple doses

Roche and Ferring collaborate on personalized female infertility treatment

Johnson & Johnson and Dana-Farber Cancer Institute establish lung cancer collaboration

DART Therapeutics changes name

Targacept begins phase I/II study of TC-6499 in diabetic gastroparesis

GSK begins phase III study of eltrombopag in myelodysplastic syndromes

Aerie Pharmaceuticals reports phase IIb results for Roclatan

Novel neurogenesis-stimulating agents disclosed by Roche

Roche divulges novel MSP receptor agonists

Bayer patent describes potential hemophilia treatments

BioMarin Pharmaceutical discloses new fusion protein for LSD

Japanese researchers present radiation-induced injury treatments

HerpV vaccine shows significant reduction in viral burden

Coronado Biosciences reports topline results from investigator-initiated pilot study

NovaBiotics begins phase IIa study of Lynovex in cystic fibrosis

Eisai submits first MAA for anticancer agent lenvatinib in Japan

Boehringer Ingelheim's idarucizumab receives FDA breakthrough therapy designation

Basilea initiates phase IIa trial of BAL-101553

Nora Therapeutics begins phase II study of NT-100 in women with recurrent pregnancy loss

Phase II results reported on refametinib in patients with pancreatic cancer

Aurinia initiates phase IIb trial of voclosporin in lupus nephritis

Cancer stemness kinase inhibitor BBI-503 tested in patients with advanced solid tumors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...